Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
RKDA 
Arcadia Biosciences Inc (RKDA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: RKDA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $12
1 Year Target Price $12
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -57.86% | Avg. Invested days 27 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 5.82M USD | Price to earnings Ratio - | 1Y Target Price 12 |
Price to earnings Ratio - | 1Y Target Price 12 | ||
Volume (30-day avg) 1 | Beta 0.52 | 52 Weeks Range 2.40 - 6.44 | Updated Date 06/30/2025 |
52 Weeks Range 2.40 - 6.44 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.57 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -38.34% | Operating Margin (TTM) -101.67% |
Management Effectiveness
Return on Assets (TTM) -30.68% | Return on Equity (TTM) -7.95% |
Valuation
Trailing PE - | Forward PE 36.63 | Enterprise Value 2507875 | Price to Sales(TTM) 1.11 |
Enterprise Value 2507875 | Price to Sales(TTM) 1.11 | ||
Enterprise Value to Revenue 0.48 | Enterprise Value to EBITDA 0.62 | Shares Outstanding 1367040 | Shares Floating 1355830 |
Shares Outstanding 1367040 | Shares Floating 1355830 | ||
Percent Insiders 0.82 | Percent Institutions 5.6 |
Analyst Ratings
Rating 1 | Target Price 12 | Buy - | Strong Buy 1 |
Buy - | Strong Buy 1 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Arcadia Biosciences Inc
Company Overview
History and Background
Arcadia Biosciences Inc. was founded in 2002. It focuses on developing and commercializing agricultural products to improve human health and the environment. Initially focused on traits to benefit growers, it has shifted towards consumer-facing products with a focus on health and wellness.
Core Business Areas
- GoodWheat: Arcadia's GoodWheat portfolio includes varieties of wheat with enhanced nutritional properties, such as high fiber and reduced gluten. It's focused on healthier wheat products for consumers.
- Body Care: The body care business sells a premium brand called SoulSpring, which includes body care for women, offering relief for hot flashes and night sweats
- Arcadia Hemp Ventures: Arcadia Hemp Ventures is where Arcadia produces hemp with high levels of CBD, and other cannabinoids. It focuses on hemp seeds and extracts for various applications.
Leadership and Structure
The leadership team includes Stan Jacot as CEO. The organizational structure is a publicly traded company with a board of directors and various management teams for different business units.
Top Products and Market Share
Key Offerings
- GoodWheat Pasta: Pasta made from Arcadia's high-fiber wheat. While specific market share data is unavailable, the competitor includes Banza (chickpea pasta) and other alternative pasta brands. Revenue data for GoodWheat Pasta is not publicly available for specific product lines.
- SoulSpring: A topical body care that provides relief for hot flashes and night sweats. While specific market share data is unavailable, competitors include brands like Womaness and other brands in menopause relief products. Revenue data for SoulSpring is not publicly available for specific product lines.
- Hemp Seeds and Extracts: Hemp seeds and extracts with high CBD content for various applications. Market is competitive, with many players like Charlotte's Web (CWBHF) and CV Sciences (CVSI) offering similar products. Revenue data for Hemp Seeds and Extracts is not publicly available for specific product lines.
Market Dynamics
Industry Overview
The agricultural biotechnology and health and wellness industries are dynamic and competitive. The demand for healthier food options and plant-based products is increasing. The hemp market is rapidly evolving with varying regulations.
Positioning
Arcadia Biosciences aims to position itself as an innovator in healthy food ingredients and consumer packaged goods and hemp ingredients, focusing on proprietary traits and health benefits. Its competitive advantage lies in its patented technologies and branded products.
Total Addressable Market (TAM)
The TAM for healthy food ingredients and hemp-derived products is estimated to be in the billions of dollars globally. Arcadia is positioned to capture a portion of this market through its GoodWheat and hemp products.
Upturn SWOT Analysis
Strengths
- Proprietary and patented technologies
- Branded products (GoodWheat, SoulSpring)
- Focus on health and wellness
- Experienced management team
Weaknesses
- Limited financial resources
- Dependence on strategic partnerships
- Limited sales and marketing reach
- Reliance on a small number of products
Opportunities
- Expanding distribution channels
- Developing new product applications for GoodWheat and hemp
- Strategic acquisitions and partnerships
- Increasing consumer awareness of health benefits
Threats
- Competition from larger agricultural companies
- Changing regulations in the hemp industry
- Commoditization of agricultural products
- Economic downturns
Competitors and Market Share
Key Competitors
- BGNE
- CWBHF
- CVSI
Competitive Landscape
Arcadia faces competition from larger, more established agricultural companies and companies in the consumer packaged goods space. Its competitive advantage lies in its novel technologies and targeted health benefits, but it needs to scale its operations and marketing efforts.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been inconsistent, with fluctuations in revenue and profitability. Past performance is not indicative of future results.
Future Projections: Analyst projections vary widely. Consult financial news sources for the latest estimates, which are subject to change.
Recent Initiatives: Recent initiatives include expanding the GoodWheat product line and developing new hemp-based products, along with body care products.
Summary
Arcadia Biosciences is a small company with innovative technologies but struggles with financial stability and market penetration. Its strengths lie in its patented GoodWheat and hemp traits, however, its weaknesses are dependence on partnerships and limited resources. Its future depends on successful commercialization and strategic partnerships to scale and compete effectively. Further the management needs to be able to effectively communicate their plan to shareholders.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Arcadia Biosciences Inc. SEC Filings (10-K, 10-Q)
- Company Website
- Third-party market research reports
- Financial news sources
Disclaimers:
This analysis is based on publicly available information and should not be considered financial advice. Market conditions and company performance can change rapidly, so it is essential to conduct thorough due diligence before making investment decisions. Financial data may be outdated or inaccurate due to recent financial restatements.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Arcadia Biosciences Inc
Exchange NASDAQ | Headquaters Dallas, TX, United States | ||
IPO Launch date 2015-05-15 | CEO, President & Director Mr. Thomas J. Schaefer C.F.A. | ||
Sector Consumer Defensive | Industry Packaged Foods | Full time employees 9 | Website https://www.arcadiabio.com |
Full time employees 9 | Website https://www.arcadiabio.com | ||
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.